SCHEMBL21688095

SCHEMBL21688095

N#Cc1ccc2c(c1)c1cc(C#N)ccc1n2-c1ccc(-c2ccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
PTGER4 P35408 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A3 P47895 2/20 0.32
GABRA2 P47869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687679 0.98 PTGER4 (0.35) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL21687714 0.93 ALDH1A3 (0.35) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL21687895 0.91 PTGER4 (0.34) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL21687712 0.91 CYP11B1 (0.34) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL21687900 0.90 PTGER4 (0.35) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL21687917 0.89 PTGER4 (0.33) PTGER4ALDH1A3PGR
SCHEMBL21688075 0.89 ALDH1A1 (0.38) FLT3MEN1KMT2AATMALDH1A1
SCHEMBL21687471 0.89 PTGER4 (0.34) PTGER4MEN1KMT2AATMALDH1A1
SCHEMBL21687794 0.88 PTGER4 (0.33) FLT3GABRA1GABRG2GABRB3GABRA5
SCHEMBL21688258 0.88 STS (0.33) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 FLT3 3632/4885GABRA1 3928/4885GABRG2 4190/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 FLT3 3632/4885GABRA1 3928/4885GABRG2 4190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.